⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Lexeo Therapeutics, Inc. Common Stock

$4.25
-0.12 (-2.63%)

Volume:

1.442M ($6.12M)

Market Capitalization:

$348.70M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Lexeo Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$4.25
Close$4.25
Low$4.25
Low Change0.00 (0.00%)
High$4.25
High Change+0.00 (+0.00%)
Range$0.00
Volume106.907K
Dollar Volume$454.35K

Regular Trading Hours

-0.19(-4.29%)
Open$4.43
Close$4.24
Low$4.21
Low Change-0.23 (-5.08%)
High$4.48
High Change+0.05 (+1.02%)
Range$0.27
Volume1.335M
Dollar Volume$5.66M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$4.36
Close$4.36
Low$4.36
Low Change0.00 (0.00%)
High$4.36
High Change+0.00 (+0.00%)
Range$0.00
Volume106.465K
Dollar Volume$464.19K

Regular Trading Hours Yesterday

-0.07(-1.47%)
Open$4.43
Close$4.37
Low$4.31
Low Change-0.12 (-2.71%)
High$4.44
High Change+0.01 (+0.23%)
Range$0.13
Volume306.165K
Dollar Volume$1.34M

Premarket Yesterday

*No Trades in Segment

Lexeo Therapeutics Top Trades

Lexeo Therapeutics's top trade so far today returned +1.07%, while the top short trade returned -5.25%.

Lexeo Therapeutics Moving Averages

5 Day Moving Average (SMA5)$4.67
10 Day Moving Average (SMA10)$4.75
20 Day Moving Average (SMA20)$4.87
50 Day Moving Average (SMA50)$4.72
100 Day Moving Average (SMA100)$4.96
200 Day Moving Average (SMA200)$6.32

Lexeo Therapeutics Statistics

Average Volume (30 Days)780.03K
P/E Ratio (Current)-4.23
EPS (Current)-$1.06
Dividend Yield0.00%
Free Cash Flow-$88.70M
Cash Ratio5.92
Current Ratio13.89
Quick Ratio13.89
Debt to Equity0.00
Enterprise Value$275.32M
EV to EBITDA-2.90
EV to Sales
Price to Book1.56
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.34%
Return on Equity-0.37%

Lexeo Therapeutics Stock Splits

There have been no stock splits for Lexeo Therapeutics (LXEO).

Lexeo Therapeutics Dividends

There have been no dividends for Lexeo Therapeutics (LXEO).